What are the payment terms accepted?

The company accepts LC and T/T as terms of payment.

What is the lead time for peak seasons?

The average lead time during peak season is one month.

What is the physical appearance of the injection?

The product is a colorless clear liquid with a salt flavor.

Sodium Chloride Injection 0.9% GMP Manufacturer

Name: Sodium Chloride Injection 0.9% GMP Manufacturer
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 852981165

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.17-0.20

20,000 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Injection

Model NO.

100ml 250ml 500ml 1000ml

Suitable for

Elderly, Adult

State

Liquid

Shape

Injection

Type

Injection

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

20044565

Transport Package

Plastic Bottle

Specification

50ml~1000ml

Trademark

SHIMEN

Origin

Hebei

HS Code

3004909099

Production Capacity

1000000

Key features

GMP Certified Manufacturer: Produced by Shijiazhuang No.4 Pharmaceutical Co., Ltd. with SFDA GMP approval.

High Production Capacity: Yearly output exceeds 1200 million bottles, including 40 million soft plastic bottles.

Global Market Reach: Products exported to South America, Africa, Asia, and Oceania regions.

Comprehensive Product Range: Manufacturer produces over 100 kinds of medicines across 7 series including infusions and tablets.

Established Brand History: Company established in 1948 with over 3000 employees and USD 58 million capital.

Multiple Packaging Options: Available in 500ml, 250ml, and 100ml soft plastic bottles.

Therapeutic Versatility: Indicated for dehydration, metabolic alkali poisoning, eye/wound washing, and labor induction.

Scientific Formulation: Chemical synthesis of NaCl with molecular weight 58.44 for electrolyte balance.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤10.13hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is identified as a Chinese public pharmaceutical manufacturer based in Hebei, with products spanning infusion solutions, injections, tablets, capsules, inhalation products, and other medical materials. The supplier reports ISO 9001, ISO 14001, and GMP certifications, more than ten production lines, automated and information-based production and logistics processes, and substantial stated output across several dosage forms. Its export activity began in 2002, although exports represent only 1%–10% of total sales. The company describes integrated R&D, manufacturing, and marketing capabilities, but the provided information does not establish specific after-sales programs, customization services, or named customer cases. Financial strength cannot be assessed because financial data is excluded.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is described as an integrated pharmaceutical enterprise covering R&D, industrial production, and marketing. Its listed business covers health and medicine products, including injections, infusion solutions, tablets, capsules, and related dosage forms.

CertificationsThe supplier reports ISO 9001, ISO 14001, and GMP certifications. It also states that production is organized strictly according to GMP requirements, providing explicit evidence of formal quality, environmental, and pharmaceutical manufacturing systems.

R&D capabilityThe supplier describes an integrated R&D, production, and marketing model, reports 50 R&D engineers, and states that its production lines integrate leading equipment and technology at an international advanced level. This supports established technical and development capability, although no specific patents, new-product results, or R&D investment details are provided.

Production capacityProduction capability is strongly supported by more than ten production lines, automated and information-based production and logistics processes, and stated annual outputs of 1.5 billion large-volume injection units and 1 billion units each for tablets, capsules, and small-volume injections. The company also reports more than ten international advanced infusion-solution lines and exports through both agency and self-operated channels.

Product Q&A

Q:What is the approval status of the manufacturer?

Shijiazhuang No.4 Pharmaceutical Co., Ltd. holds GMP approval by the SFDA of China.

Q:What are the main indications for this injection?

It is indicated for dehydration caused by various cases, low-chloride metabolic alkali poisoning, and can be used for washing eyes, wounds, and labor induction.

Q:What packaging sizes are available?

The product is available in 500ml, 250ml, and 100ml soft plastic bottles.

Q:Which regions does the company export to?

Products are sold to South America, Africa, Asia, Southeast Asia, Oceania, and the Middle East.

Q:What is the chemical composition of the product?

The main ingredient is Sodium Chloride (NaCl) with a molecular weight of 58.44.